Avanos Medical (AVNS) Gross Margin (2013 - 2026)
Avanos Medical (AVNS) reported Gross Margin of 51.7% for Q1 2026, down 191.0% on a YoY basis from 56.81% in Q1 2025, and up 8.75% sequentially from 47.54% in Q4 2025.
Avanos Medical (AVNS) Gross Margin (2013 - 2026) Analysis & Trends
Avanos Medical (AVNS) has 14 years of Gross Margin data on file, last reported at 51.7% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin fell 191.0% year-over-year to 51.7%; the trailing twelve-month figure through Mar 2026 stood at 50.05% (down 455.0% YoY), and the FY2025 full-year result was 50.47%, down 497.0% from the prior year.
- Gross Margin climbed to 51.7% in Q1 2026, from 47.54% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 59.45% in Q2 2022 to a low of 47.54% in Q4 2025.
- A 5-year average of 54.68% and a median of 54.82% in 2023 frame the typical range for Gross Margin.
- Peak annual rise in Gross Margin reached 1347 bps in 2022, while the deepest fall reached 3356 bps in 2022.
- Tracing AVNS's Gross Margin over 5 years: stood at 56.66% in 2022, then declined by 3 bps to 54.82% in 2023, then fell by 0 bps to 54.57% in 2024, then fell by 13 bps to 47.54% in 2025, then increased by 9 bps to 51.7% in 2026.
- Business Quant data shows AVNS's Gross Margin at 51.7% in Q1 2026, 47.54% in Q4 2025, and 48.37% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Avanos Medical | 1.16 Bn | 1.10 Bn | 94.20 Mn | 51.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.70% |
| Dec 31, 2025 | 47.54% |
| Sep 30, 2025 | 48.37% |
| Jun 30, 2025 | 52.63% |
| Mar 31, 2025 | 53.61% |
| Dec 31, 2024 | 54.57% |
| Sep 30, 2024 | 54.52% |
| Jun 30, 2024 | 55.68% |
| Mar 31, 2024 | 57.07% |
| Dec 31, 2023 | 54.82% |
| Sep 30, 2023 | 55.75% |
| Jun 30, 2023 | 57.73% |
| Mar 31, 2023 | 57.38% |
| Dec 31, 2022 | 56.66% |
| Sep 30, 2022 | 58.15% |
| Jun 30, 2022 | 59.45% |
| Mar 31, 2022 | 54.00% |
| Dec 31, 2021 | 90.22% |
| Sep 30, 2021 | 49.00% |
| Jun 30, 2021 | 45.98% |